Drugs.com - New Drug Approvals

FDA Approves Miudella (copper intrauterine system) for the Prevention of Pregnancy

ROSWELL, GA, February 24, 2025 – Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) granted approval of Miudella (copper intrauterine system) for the prevention...

Feb 26, 2025 - 07:20
 0
FDA Approves Miudella (copper intrauterine system) for the Prevention of Pregnancy
ROSWELL, GA, February 24, 2025 – Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) granted approval of Miudella (copper intrauterine system) for the prevention...
Read More

Tags:

Previous Article

29Metals trims annual loss but still has work to do

Next Article

Stations to get clearer announcements

Related Posts

FDA Approves Lumakras (sotorasib) in Combination with Vectibix (panitumumab) for Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer

FDA Approves Lumakras (sotorasib) in Combination with V...

Feb 9, 2025  0

FDA Approves Journavx (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

FDA Approves Journavx (suzetrigine), a First-in-Class T...

Feb 9, 2025  0

FDA Approves Datroway (datopotamab deruxtecan-dlnk) for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer

FDA Approves Datroway (datopotamab deruxtecan-dlnk) for...

Feb 9, 2025  0